These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9303402)

  • 1. Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin.
    Forney JR; Yang S; Healey MC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2006-8. PubMed ID: 9303402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system.
    Forney JR; Yang S; Du C; Healey MC
    J Parasitol; 1996 Aug; 82(4):638-40. PubMed ID: 8691375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic effect of human alpha-1-antitrypsin on excystation of Cryptosporidium parvum oocysts.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1997 Aug; 83(4):771-4. PubMed ID: 9267429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticryptosporidial potential of alpha-1-antitrypsin.
    Forney JR; Yang S; Healey MC
    J Eukaryot Microbiol; 1996; 43(5):63S. PubMed ID: 8822860
    [No Abstract]   [Full Text] [Related]  

  • 5. Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery.
    Griffiths JK; Balakrishnan R; Widmer G; Tzipori S
    Infect Immun; 1998 Aug; 66(8):3874-83. PubMed ID: 9673275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the human serine protease inhibitor alpha-1-antitrypsin with Cryptosporidium parvum.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1996 Jun; 82(3):496-502. PubMed ID: 8636860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cells: a new screening method for anticryptosporidial agents.
    Favennec L; Egraz-Bernard M; Comby E; Lemeteil D; Ballet JJ; Brasseur P
    J Eukaryot Microbiol; 1994; 41(5):39S. PubMed ID: 7804239
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ginsenoside-Rh2 and Curcurbitacin-B on Cryptosporidium parvum in vitro.
    Shahiduzzaman M; Ras R; Widmer G
    Exp Parasitol; 2020 May; 212():107873. PubMed ID: 32165146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry based assay to determine the effects of treatments on Cryptosporidium parvum viability.
    Phelps KK; Lindsay DS; Sumner SS; Fayer R
    J Eukaryot Microbiol; 2001; Suppl():40S-41S. PubMed ID: 11906073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum.
    Verdon R; Keusch GT; Tzipori S; Grubman SA; Jefferson DM; Ward HD
    J Infect Dis; 1997 May; 175(5):1268-72. PubMed ID: 9129102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells.
    Yang S; Healey MC; Du C; Zhang J
    Infect Immun; 1996 Jan; 64(1):349-54. PubMed ID: 8557363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines.
    Giacometti A; Cirioni O; Barchiesi F; Scalise G
    J Antimicrob Chemother; 2000 Mar; 45(3):375-7. PubMed ID: 10702561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line.
    Marshall RJ; Flanigan TP
    J Infect Dis; 1992 Apr; 165(4):772-4. PubMed ID: 1552210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Hommer V; Eichholz J; Petry F
    J Antimicrob Chemother; 2003 Sep; 52(3):359-64. PubMed ID: 12888587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.
    Gargala G; Baishanbo A; Favennec L; François A; Ballet JJ; Rossignol JF
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4628-34. PubMed ID: 16251305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum.
    You X; Schinazi RF; Arrowood MJ; Lejkowski M; Juodawlkis AS; Mead JR
    J Antimicrob Chemother; 1998 Feb; 41(2):293-6. PubMed ID: 9533476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activity associated with excystation of Cryptosporidium parvum oocysts.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1996 Dec; 82(6):889-92. PubMed ID: 8973395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticryptosporidial activity of paromomycin.
    Cirioni O; Giacometti A; Balducci M; Drenaggi D; Del Prete MS; Scalise G
    J Infect Dis; 1995 Oct; 172(4):1169-70. PubMed ID: 7561208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.